Details of the Drug

General Information of Drug (ID: DMKYJJC)

Drug Name

Tigatuzumab

Indication

Disease Entry	ICD 11	Status	REF
Breast cancer	2C60-2C65	Phase 2	[1]
Colorectal cancer	2B91.Z	Phase 2	[1]
Liver cancer	2C12	Phase 2	[1]
Ovarian cancer	2C73	Phase 2	[1]
Pancreatic cancer	2C10	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Monoclonal antibody

Cross-matching ID

Repurposed Drugs (RPD)

References

1	ClinicalTrials.gov (NCT01307891) Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer. U.S. National Institutes of Health.